IDEXX Laboratories, Inc. (BMV:IDXX)

Market Cap	934.81B
Revenue (ttm)	76.14B
Net Income (ttm)	18.59B
Shares Out	n/a
EPS (ttm)	226.52
PE Ratio	50.29
Forward PE	47.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	4
Open	11,670
Previous Close	11,670
Day's Range	11,670 - 11,670
52-Week Range	7,650 - 12,868
Beta	n/a
RSI	49.54
Earnings Date	Nov 3, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: IDXX

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD